Issue Date: Sep 30, 2010
On July 15, 1962, a Washington Post story, ‘Heroine of FDA keeps bad drug off market,’ shocked Americans. The heroine in question was Frances Oldham Kelsey. She had joined the US Food and Drug Administration two years earlier as a drug application investigator. With her expertise in pharmacology, she was the obvious choice to test the veracity of an application for a “harmless” sedative that was already being sold in 46 countries. The drug, Kevadon, was one of the trade names of thalidomide.
Cheryl Colopy‘s book explores how south Asian rivers have been transformed from being considered sacred beings to sewers
How a township has set high standard for eco-friendly living
The UN environment report states that Ganga would disappear by 2030.There would be no need to train engineers or even Ganga...
A report published in the Journal of the Federation of American Societies for Experimental Biology suggests that babies of...
Yes, the happening and looming threat of the loss of Bio-cultural diversity stares us in the face. This is particularly true...